Latest News

Do Organophosphate Esters Increase Thyroid Disease Risk?


 

TOPLINE:

Exposure to organophosphate ester (OPE) metabolites, a newer group of widely used chemical flame retardants, is linked to a higher risk for thyroid disease, bis(2-chloroethyl) phosphate (BCEP) being the main contributor.

METHODOLOGY:

  • Prior studies have reported that OPEs β€” used in building materials, electronic products, furniture, and textiles β€” may interfere with thyroid function, hinting at a possible association of OPEs with thyroid disease.
  • Researchers assessed the association between OPE exposure and the risk for thyroid disease using data from the 2011-2014 US National Health and Nutrition Examination Survey cycle.
  • They included 2449 participants (mean age, 46 years; half of whom were women) who had complete values for seven OPE metabolites through urinalysis and completed questionnaires regarding the presence of thyroid disease.
  • The seven OPE metabolites assessed in this study were diphenyl phosphate (DPHP), bis(1,3-dichloro-2-propyl) phosphate, bis(1-chloro-2-propyl) phosphate, BCEP, dibutyl phosphate, dibenzyl phosphate, and 2,3,4,5-tetrabromobenzoic acid.
  • Several mixed exposure models were used to investigate the associations between the risk for thyroid disease and exposure to individual and mixed OPEs.

TAKEAWAY:

  • A history of thyroid disease was self-reported by 228 participants.
  • In one model, the risk for thyroid disease was 57% higher in people in the highest vs the lowest tertile of BCEP exposure (P = .005).
  • A newer method confirmed the positive association between exposure to mixed OPE metabolites and a higher risk for thyroid disease (odds ratio, 1.03; P = .013), with BCEP (65%) being the main contributing factor, followed by DPHP (35%).
  • A model from another new method showed a J-shaped relationship between the risk for thyroid disease and increasing levels of BCEP exposure, in which the risk first dropped but then rose with increasing exposure.

IN PRACTICE:

β€œThe three models in our study provided similar results, with exposure to mixed OPEs having a tendency to increase the risk of thyroid disease and pointing to BCEP as the most significant compound responsible for this trend,” wrote the authors.

SOURCE:

This study was led by Yuxin Lin, from the Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, China, and published online in Frontiers in Endocrinology.

LIMITATIONS:

The cross-sectional design cannot establish a causal relationship between OPE exposure and thyroid disease. The study used unweighted data, which could have limited the generalizability of the findings. Moreover, urine sample measurements were performed only once.

DISCLOSURES:

The study was supported by the Fujian Natural Science Foundation Program and the Scientific Research Program of High-level Talents of Fujian Medical University. The authors declared no potential conflicts of interest.

A version of this article first appeared on Medscape.com.

Recommended Reading

Anti-Rheumatic Drugs Linked to Reduced Thyroid Disease Incidence
MDedge Endocrinology
Study Suggests Inappropriate Use of Thyroid Ultrasounds
MDedge Endocrinology
Thyroidectomy Beneficial but Risky for Hashimoto Disease
MDedge Endocrinology
Autoimmune Diseases and Perinatal Depression May Share Two-Way Link
MDedge Endocrinology
Direct Measurement of T3 Is Likely Vital, Say Researchers
MDedge Endocrinology
EHR Tool Enhances Primary Aldosteronism Screening in Hypertensive Patients
MDedge Endocrinology
Selenium Supplementation Shows Thyroid Benefits
MDedge Endocrinology
Autoimmune Disease Risk May Rise Following Cushing Disease Remission After Surgery
MDedge Endocrinology
Thyroid Disorders and Gynecologic Cancers: Is There a Link?
MDedge Endocrinology
Is Adrenal Fatigue a Real Condition?
MDedge Endocrinology